Tissue Factor Pathway Inhibitor-1 Is a Valuable Marker for the Prediction of Deep Venous Thrombosis and Tumor Metastasis in Patients with Lung Cancer

Table 3

Multivariate Logistic regression analysis of risk factors for complicating DVT in NSCLC patients.

Variables	Partial regression coefficient	Standard error	Wald X^2	OR (95% CI)
TFPI-1	1.35	0.55	6.22	4.15 (2.00–8.35)	0.020
AT	1.14	0.38	7.29	3.22 (2.25–5.85)	0.011
Fbg	0.90	0.43	8.01	2.58 (1.15–6.21)	0.004
FVIII:C	0.75	0.50	5.55	1.80 (1.52–6.58)	0.035
D-D	0.56	0.35	10.32	1.35 (1.10–5.22)	<0.001

NSCLC: non-small cell lung cancer. DVT: deep venous thrombosis. TFPI-1: tissue factor pathway inhibitor-1. AT: antithrombin. Fbg: fibrinogen. FVIII:C: coagulating factor VIII procoagulant activity. D-D: D-dimer. OR: odds ratio. CI: confidence interval.